MANNATECH INC (MTEX)

US5637712036 - Common Stock

8.2757  +0.09 (+1.05%)

Fundamental Rating

2

Taking everything into account, MTEX scores 2 out of 10 in our fundamental rating. MTEX was compared to 37 industry peers in the Personal Care Products industry. MTEX may be in some trouble as it scores bad on both profitability and health. MTEX has a expensive valuation and it also scores bad on growth.



Quickly go to:

2

1. Profitability

1.1 Basic Checks

MTEX had negative earnings in the past year.
In the past year MTEX has reported a negative cash flow from operations.
In multiple years MTEX reported negative net income over the last 5 years.
In multiple years MTEX reported negative operating cash flow during the last 5 years.

1.2 Ratios

MTEX's Return On Assets of -5.47% is on the low side compared to the rest of the industry. MTEX is outperformed by 62.16% of its industry peers.
The Return On Equity of MTEX (-21.52%) is worse than 64.86% of its industry peers.
Industry RankSector Rank
ROA -5.47%
ROE -21.52%
ROIC N/A
ROA(3y)0.61%
ROA(5y)3.35%
ROE(3y)-4.29%
ROE(5y)4.69%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

MTEX has a better Gross Margin (77.92%) than 94.59% of its industry peers.
In the last couple of years the Gross Margin of MTEX has remained more or less at the same level.
MTEX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.61%
GM growth 5Y-0.55%

More info and screens

3

2. Health

2.1 Basic Checks

MTEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MTEX has less shares outstanding
Compared to 5 years ago, MTEX has less shares outstanding
MTEX has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 3.44 indicates that MTEX is not in any danger for bankruptcy at the moment.
The Altman-Z score of MTEX (3.44) is better than 70.27% of its industry peers.
MTEX has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
MTEX has a Debt to Equity ratio (0.09) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 3.44
ROIC/WACCN/A
WACC9.26%

2.3 Liquidity

MTEX has a Current Ratio of 1.07. This is a normal value and indicates that MTEX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.07, MTEX is doing worse than 75.68% of the companies in the same industry.
A Quick Ratio of 0.51 indicates that MTEX may have some problems paying its short term obligations.
With a Quick ratio value of 0.51, MTEX is not doing good in the industry: 83.78% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 0.51

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 49.62% over the past year.
The Revenue has decreased by -3.79% in the past year.
MTEX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.34% yearly.
EPS 1Y (TTM)49.62%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q72.4%
Revenue 1Y (TTM)-3.79%
Revenue growth 3Y-4.48%
Revenue growth 5Y-5.34%
Revenue growth Q2Q-4.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MTEX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MTEX is valued a bit cheaper than 62.16% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.68

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

MTEX has a Yearly Dividend Yield of 2.44%. Purely for dividend investing, there may be better candidates out there.
MTEX's Dividend Yield is rather good when compared to the industry average which is at 4.99. MTEX pays more dividend than 83.78% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, MTEX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.44%

5.2 History

The dividend of MTEX decreases each year by -19.97%.
MTEX has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-19.97%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of MTEX are negative and hence is the payout ratio. MTEX will probably not be able to sustain this dividend level.
DP-33.16%
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

MANNATECH INC

NASDAQ:MTEX (4/29/2024, 7:15:30 PM)

8.2757

+0.09 (+1.05%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap15.56M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.44%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.47%
ROE -21.52%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 77.92%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover3.2
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.07
Quick Ratio 0.51
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)49.62%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-3.79%
Revenue growth 3Y-4.48%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y